Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, Par Value $0.0001 Per Share
-
Shares outstanding
-
23,267,064
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
8,980,924
-
Shares change
-
+360,633
-
Total reported value, excl. options
-
$1,012,208,421
-
Value change
-
-$4,920,541
-
Put/Call ratio
-
20%
-
Number of buys
-
68
-
Number of sells
-
-82
-
Price
-
$112.72
Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) as of Q4 2018
190 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share as of Q4 2018.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,980,924 shares
of 23,267,064 outstanding shares and own 39% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (1,664,452 shares), BAKER BROS. ADVISORS LP (1,169,278 shares), Vanguard Group Inc (746,976 shares), HealthCor Management, L.P. (688,890 shares), STATE STREET CORP (600,427 shares), BlackRock Inc. (533,010 shares), JPMORGAN CHASE & CO (390,495 shares), ALLIANCEBERNSTEIN L.P. (306,134 shares), JENNISON ASSOCIATES LLC (281,071 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (261,019 shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.